Latest news with #BavarianNordic
The Sun
22-05-2025
- Health
- The Sun
US CDC accepts recommendations for chikungunya vaccines.
THE U.S. CENTERS for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya, a virus transmitted by mosquitoes. The recommendations were approved on May 13, 2025, and are now the official recommendations of the CDC. The final recommendations will assist physicians in choosing appropriate vaccines for patients and will also guide insurance coverage policies in the U.S. The health agency is also expected to decide on recommendations for vaccines against respiratory syncytial virus (RSV) and meningococcal disease, a bacterial infection. However, details regarding the approval status of the RSV and meningococcal vaccine recommendations are currently not available on the CDC's website. Both Bavarian Nordic and Valneva make vaccines for chikungunya.
The Sun
22-05-2025
- Health
- The Sun
CDC Recommends Chikungunya Vaccines
THE U.S. CENTERS for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya, a virus transmitted by mosquitoes. The recommendations were approved on May 13, 2025, and are now the official recommendations of the CDC. The final recommendations will assist physicians in choosing appropriate vaccines for patients and will also guide insurance coverage policies in the U.S. The health agency is also expected to decide on recommendations for vaccines against respiratory syncytial virus (RSV) and meningococcal disease, a bacterial infection. However, details regarding the approval status of the RSV and meningococcal vaccine recommendations are currently not available on the CDC's website. Both Bavarian Nordic and Valneva make vaccines for chikungunya.
Reuters
21-05-2025
- Health
- Reuters
US CDC accepts recommendations for chikungunya vaccines
May 6 (Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines for chikungunya, a virus transmitted by mosquitoes. The recommendations were approved on May 13, 2025, and are now the official recommendations of the CDC. The final recommendations will assist physicians in choosing appropriate vaccines for patients and will also guide insurance coverage policies in the U.S. The health agency is also expected to decide on recommendations for vaccines against respiratory syncytial virus (RSV) and meningococcal disease, a bacterial infection. However, details regarding the approval status of the RSV and meningococcal vaccine recommendations are currently not available on the CDC's website. Both Bavarian Nordic ( opens new tab and Valneva ( opens new tab make vaccines for chikungunya.
Time of India
13-05-2025
- Health
- Time of India
US health officials advise older travelers not to get a chikungunya vaccine
New York: The U.S. government advised American travelers age 60 and older not get a chikungunya vaccine as it investigates possible side effects. The Centers for Disease Control and Prevention and the Food and Drug Administration posted notices late last week on the vaccine, Valneva's Ixchiq . Chikungunya, spread by the bites of infected mosquitoes, is a debilitating tropical illness marked by fever and joint pain. About 100 to 200 cases are reported annually among U.S. travelers. Last year, the government began recommending the vaccine, which is made with weakened chikungunya virus, to U.S. adults who travel to countries where chikungunya is a problem. But last month, a panel of vaccine experts who advise the CDC heard about an investigation into six people 65 and older - most of them with other medical problems - who became ill with heart or brain symptoms less than a week after vaccination. More than 10 other similar cases have been reported in people from other countries. European regulators are also looking into the issue. The U.S. advisers voted to issue a precaution for people 65 and older about getting the vaccine. They also recommended that a second chikungunya vaccine - Bavarian Nordic's Vimkunya - be made available for people age 12 and older who are traveling to countries where outbreaks of the mosquito-borne illness are occurring. CDC officials have not yet announced whether they will accept those recommendations.
Time of India
13-05-2025
- Health
- Time of India
US advises older adults to avoid the chikungunya vaccine
Image credits: Getty Images The Centers for Disease Control and Prevention and the Food and Drug Administration posted notices late last week, advising American travellers age 60 and above to avoid taking the chikungunya vaccine , Valneva's Ixchiq . In 2024, the government began recommending the vaccine made from the weakened chikungunya virus to adults who were travelling to countries where chikungunya is a problem. However, in April, a panel of vaccine experts who advise the CDC heard about an investigation into 6 people aged 65 and older, most of whom had medical problems, who became ill with heart or brain-related issues within a week of vaccination. More than 10 similar cases have been reported in people from other countries. While the European regulators are looking into the issue, U.S. advisers have voted to practice precaution for people 65 and older in regards of getting the vaccine. Additionally, the U.S. advisors have also recommended that the second chikungunya vaccine, Bavarian Nordic's Vimkunya , be made available for people 12 and older who are travelling to countries where chikungunya outbreaks are occurring. CDC officials have not yet announced if they have accepted the recommendations. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like AI guru Andrew Ng recommends: Read These 5 Books And Turn Your Life Around in 2025 Blinkist: Andrew Ng's Reading List Undo Chikungunya, spread by bites of infected mosquitoes, is an increasing tropical illness with symptoms such as fever and joint pain. About 100 to 200 cases are reported annually among American travellers. According to the Centers for Disease Control and Prevention, people infected with chikungunya will usually begin to see symptoms within 3-7 days. While common symptoms include fever and joint pain other symptoms such as headache, muscle pain, joint swelling or rash. Some ways to prevent the disease are using insect repellent, wearing long-sleeved shirts and pants and treating clothing and gear with 0. 5% permethrin. Get the latest lifestyle updates on Times of India, along with Mother's Day wishes , messages , and quotes !
